RESHAPE LIFESCIENCES INC (RSLS) Forecast, Price Target & Analyst Ratings
NASDAQ:RSLS • US76090R3093
3.92 USD
+0.72 (+22.5%)
At close: Aug 14, 2025
3.22 USD
-0.7 (-17.86%)
After Hours: 8/14/2025, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RESHAPE LIFESCIENCES INC (RSLS).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateNov 12, 2025
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.92 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
RSLS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about RSLS.
In the previous month the buy percentage consensus was at a similar level.
RSLS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-07-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-05-26 | Alliance Global Partners | Maintains | Buy |
| 2021-10-08 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 12, 2025
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 11.24M -17.35% | 8.678M -22.79% | 8.006M -7.74% | 12.233M 52.80% | |
| EBITDA YoY % growth | -24.93M 1.31% | -14.485M 41.90% | -6.646M 54.12% | N/A | |
| EBIT YoY % growth | -27.08M 0.55% | -14.639M 45.94% | -6.668M 54.45% | -5.934M 11.00% | |
| Operating Margin | -240.93% | -168.69% | -83.29% | -48.51% | |
| EPS YoY % growth | -118,305.50 86.40% | -5,147.91 95.65% | N/A 99.99% | -0.37 20.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
RESHAPE LIFESCIENCES INC / RSLS Forecast FAQ
What is the next earnings date for RSLS stock?
RESHAPE LIFESCIENCES INC (RSLS) will report earnings on 2025-11-12.
Can you provide the analyst count for RESHAPE LIFESCIENCES INC stock?
The number of analysts covering RESHAPE LIFESCIENCES INC (RSLS) is 6.